Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Nippon Kayaku evaluates novel doxorubicin preparation

Oct. 11, 1996

Antitumor antibiotics from the Kitasato Institute

Oct. 11, 1996

FK-317, a new antitumor antibiotic from Fujisawa

Oct. 11, 1996

U.S. Bioscience and Schering-Plough revise Ethyol agreement

Oct. 4, 1996

VX-853 for MDR reversal receives patent coverage

Oct. 4, 1996

Inhibitors of endothelial cell proliferation from Sumitomo

Oct. 4, 1996

Human Genome Sciences discloses novel approach to malignancy

Oct. 4, 1996

Anticancer MMP inhibitor enters clinical trials

Oct. 4, 1996

Takeda's anticancer drug pipeline reviewed

Sep. 27, 1996

Promising preclinical and clinical results for Genta's lead antisense compound

Sep. 27, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
Capital remains selective in ‘barbell’ biotech market
BioWorld
Signs of recovery are emerging in the biotechnology investment sector, although investors across Asia say that capital is flowing selectively to companies that...
PSB-229 reduces plaque burden in Alzheimer’s models
BioWorld Science
Pyroglutamate-modified amyloid-β (pE3-Aβ) is a highly pathogenic Aβ species that accumulates within amyloid plaques and contributes to aggregation,...